Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 11, 2022
Reporting Period: Preliminary results for the fourth quarter and full fiscal year 2021.
Key Financial Metrics
This filing serves as a notification of a press release (Exhibit 99.1) containing preliminary financial results. The text of this 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for detailed metrics.
Material Changes
The filing discloses the issuance of preliminary financial results for Q4 and FY 2021. No specific comparative data or material changes versus prior periods are detailed within the body of this report.
Guidance, Outlook, and Management Commentary
- Regulation FD Disclosure: On January 13, 2022, the Company distributed a letter to stockholders providing a business update (Exhibit 99.2).
- Management Commentary: The filing references a press release for financial details but does not contain direct management commentary or forward-looking guidance in the text provided.
- Risks and Contingencies: No specific risks or contingencies are detailed in this summary report.
Important Facts for Investor Verification
- Verify the specific revenue and net loss figures in the press release dated January 11, 2022 (Exhibit 99.1).
- Review the stockholder letter dated January 13, 2022 (Exhibit 99.2) for qualitative business updates.
- Confirm that the preliminary results are not deemed "filed" for liability purposes under Section 18 of the Exchange Act, as noted in Item 2.02.